Binh Dinh Pharmaceutical And Medical Equipment JSC's quarterly raw materials
declined
from Sep. 2025 (₫222,029 Mil) to Dec. 2025 (₫202,545 Mil) but then
increased
from Dec. 2025 (₫202,545 Mil) to Mar. 2026 (₫256,240 Mil).
Binh Dinh Pharmaceutical And Medical Equipment JSC's annual raw materials
declined
from Dec. 2023 (₫300,345 Mil) to Dec. 2024 (₫247,153 Mil) and
declined
from Dec. 2024 (₫247,153 Mil) to Dec. 2025 (₫202,545 Mil).
Binh Dinh Pharmaceutical And Medical Equipment JSC Inventories, Raw Materials & Components Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC Inventories, Raw Materials & Components Chart
Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data
What does a Inventories, Raw Materials & Components of ₫256,240 Mil mean?
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a Inventories, Raw Materials & Components of ₫256,240 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's Inventories, Raw Materials & Components too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current Inventories, Raw Materials & Components is ₫256,240 Mil. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's Inventories, Raw Materials & Components compare to ZTS?
Binh Dinh Pharmaceutical And Medical Equipment JSC's Inventories, Raw Materials & Components of ₫256,240 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. Binh Dinh Pharmaceutical And Medical Equipment JSC's current Inventories, Raw Materials & Components is ₫256,240 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,212.47, compared to a current price of ₫53,200.00 — trading 1.9% above its estimated fair value. The current Inventories, Raw Materials & Components is ₫256,240 Mil. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current Inventories, Raw Materials & Components is ₫256,240 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be overvalued.
The current stock price of ₫53,200.00 is trading 1.9% above its estimated GF Value™ of ₫52,212.47.
GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.
Key valuation signals for STC:DBD:
Inventories, Raw Materials & Components: ₫256,240 Mil
GF Value™: ₫52,212.47 vs. price of ₫53,200.00 (1.9% above fair value)
No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Binh Dinh Pharmaceutical And Medical Equipment JSC Business Description
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
82GF Score
Get the complete analysis for STC:DBD
Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DBD has been successfully added to your 
